Oraya TherapyTM Stereotactic Radiotherapy for Wet AMD



The Oraya Therapy is available in Germany, Switzerland and the United Kingdom. For more information:
In Germany, call +49 (0)911-376564 44
In Switzerland, call 41-61-4266000
In the United Kingdom, call 0800-690-6495
Find a treatment location >


Published Articles
Radiotherapy for Wet AMD: Real-world results of stereotactic radiotherapy have begun to emerge

Retinal Physician, 2015 Nov:51-55
Read Now >

Low-energy Stereotactic Radiotherapy for Treatment of Exudative Age-related Macular Degeneration Adjunctive to Anti-VEGF Therapy

European Ophthalmic Review, 2015;9(1):25–31
Read Now >

Use of Low-Voltage X-Ray Adjunctive to Anti-VEGF Therapy in the Treatment of Wet AMD

Retina Today, 2015 May:86-89
Read Now >

Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: Year 2 Results of the INTREPID Study

Ophthalmology, 2015 Jan;122(1):138-145
Free Download >


Leading Ophthalmologists

Leading Ophthalmologists Present Real World Clinical Outcomes on Oraya Therapy for Wet AMD at EURETINA 15th Congress.

Video Presentations
Watch Videos >

Written Supplement
Download >

Press Release
Download >


In the News

BBC Radio Sheffield – Interview: Consultant Ophthalmologist Chris Brand discusses treatment results for his wet AMD patients. Play >

Oraya Therapy Video


Age-Related Macular Degeneration (AMD) is a progressive disease that causes loss of central vision leading to blindness. It is the primary cause of vision loss for seniors in the industrialized world. While there is no cure for AMD, the Oraya Therapy™ for Wet AMD is an exciting new treatment.   More >


Founded in 2007, Oraya® Therapeutics, Inc. is a privately held company developing an innovative and non-invasive therapy designed to advance the treatment options for wet AMD.  More >


Physicians and patients require a new option and a new vision for the treatment of wet AMD. Oraya Therapy— intended as a one-time, non-invasive procedure—uses a low-voltage, stereotactic approach. It delivers precisely controlled X-rays confined to the diseased area of interest, sparing the surrounding structures of the eye.  More >

© 2016 All rights reserved. Oraya Therapeutics, Inc. The IRay® is a CE-marked medical device. The IRay is not available for sale in the United States. For additional details, including safety and risk information, please see the ORAYA THERAPY section of this website. Oraya, Oraya Therapy, IRay and I-Guide are either trademarks or registered trademarks of Oraya Therapeutics, Inc. in the United States and other countries.